tm logo
PXB-SHIZUKU
Live/Registered
REGISTERED

on 17 Dec 2024

Last Applicant/ Owned by

Higashi-Hiroshima-shi Hiroshima 739-0046

JP

Serial Number

79378897 filed on 25th Jul 2023

Registration Number

7602251 registered on 17th Dec 2024

in the Principal Register

Correspondent Address

Jeffrey H. Handelsman

Jeffrey H. Handelsman Greenblum & Bernstein, P.L.C.

Reston, VA 20191-1411

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

PXB-SHIZUKU

Chemicals for use in industry and science; biological preparations, other than for medical or veterinary purposes; cells for scientific and research use; cells for scientific or research use, other than for medical or veterinary purposes; cell culture medium for scientific or research use, other than for medical or veterinary use; cell culture conditioned medium for scientific or research use, oth Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for treatment of diabetes mellitus, liver disease treatment, surgical treatment, neurological disease treatment, dyslipidemia treatment, treatment of blood coagulation disorders, treatment of metabolic disorders of iron and copper, treatment of congenital metabolic disorders, treatment of trace element deficiency, treatment of infectious diseases for use in regenerative medicine; medicines for treatment of diabetes mellitus, liver disease treatment, surgical treatment, neurological disease treatment, dyslipidemia treatment, treatment of blood coagulation disorders, treatment of metabolic disorders of iron and copper, treatment of congenital metabolic disorders, treatment of trace element deficiency, treatment of infectious diseases for use in regenerative medicine for human purposes; medicines for treatment of diabetes mellitus, liver disease treatment, surgical treatment, neurological disease treatment, dyslipidemia treatment, treatment of blood coagulation disorders, treatment of metabolic disorders of iron and copper, treatment of congenital metabolic disorders, treatment of trace element deficiency, treatment of infectious diseases for use in regenerative medicine for veterinary purposes; cells for medical or veterinary purposes; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; cell culture medium for medical and veterinary purposes; cell culture conditioned medium for medical and veterinary purposes; supernatant of cell culture medium for medical and veterinary purposes; supernatant fluid of cell culture medium for medical and veterinary purposes


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products


Chemicals for use in industry and science; biological preparations, other than for medical or veterinary purposes; cells for scientific and research use; cells for scientific or research use, other than for medical or veterinary purposes; cell culture medium for scientific or research use, other than for medical or veterinary use; cell culture conditioned medium for scientific or research use, other than for medical or veterinary purposes; supernatant of cell culture medium for scientific or research use, other than for medical or veterinary purposes; supernatant fluid of cell culture medium for scientific or research use, other than for medical or veterinary purposes


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79378897

Mark Type

No Service/Collective Mark

Attorney Docket Number

No T71265

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
17th Dec 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
17th Dec 2024REGISTERED-PRINCIPAL REGISTER
15th Oct 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15th Oct 2024PUBLISHED FOR OPPOSITION
25th Sep 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08th Sep 2024APPROVED FOR PUB - PRINCIPAL REGISTER
19th Aug 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
19th Aug 2024TEAS/EMAIL CORRESPONDENCE ENTERED
19th Aug 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
29th May 2024NOTIFICATION OF FINAL REFUSAL EMAILED